Primary Care Alliance

Primary Care Alliance

Primary Care Alliance

Contact Us Join Today
  • Why A Buying Group
    • Program Overview
    • Member Benefits
    • How It Works
    • FAQ
  • Why Choose PCA
    • How do you decide which PBG to join?
    • Background Information
    • Who We Are
  • Manufacturing Partners
    • AstraZeneca
    • CSL Seqirus
    • Merck
      • Enflonsia
    • Moderna
    • Pfizer
      • Abrysvo
    • Sanofi
      • Beyfortus
      • Vaxelis
  • VaccineShop
  • Resources
    • Vaccine Information for Your Staff and Patients
    • Catching Up Patients Who Are Behind on Vaccines
    • Vaccinating Pregnant Women
    • Influenza Vaccine Resources
    • RSV Vaccine Resources
    • COVID-19 Vaccine Resources
  • Blog

Home | Archives for pcalliance

On January 26, 2026, the American Academy of Pediatrics (AAP) released the Recommended Childhood and Adolescent Immunization Schedule: United States, 2026. The schedule outlines vaccine recommendations that differ in several areas from those recently issued by the Centers for Disease Control and Prevention (CDC).

Rather than adopting the CDC’s updates, the AAP maintained its long-standing recommendations for routine immunization against 18 diseases, including hepatitis A, rotavirus, influenza, respiratory syncytial virus (RSV), and meningococcal disease.

Vaccines Recommended for All Children by Both the AAP and CDC:

Both organizations continue to recommend routine vaccination for:

  • Measles, mumps, rubella (MMR)
  • Diphtheria, tetanus, pertussis (DTaP and Tdap)
  • Polio (IPV)
  • Haemophilus influenzae type B (Hib)
  • Pneumococcal disease (PCV)
  • Human papillomavirus (HPV)
  • Varicella

Additional Vaccines the AAP Continues to Recommend

In contrast to the CDC’s updated guidance, the AAP continues to recommend routine use of the following vaccines or preventive products:

  • RSV monoclonal antibodies
  • Hepatitis A (HepA)
  • Hepatitis B (HepB)
  • Meningococcal ACWY (MenACWY)
  • Meningococcal B (MenB)
  • Rotavirus (RV)
  • COVID-19

Why did the AAP Maintain its Immunization Schedule?

The AAP has a long history of issuing evidence-based vaccine guidance and, for many years, collaborated with the CDC and other organizations to produce unified immunization recommendations. Ongoing differences between the organizations led the AAP to publish an independent schedule in August 2025, which largely remains in place for 2026.

One notable difference involves COVID-19 vaccination. In its August 2025 schedule, the AAP recommended COVID-19 vaccination for all children aged 6–23 months, as well as older children in certain risk groups. The CDC, by contrast, places COVID-19 vaccination under shared clinical decision-making. Dr. Pia Pannaraja, a member of the AAP Committee on Infectious Diseases and professor of pediatrics at the University of California, San Diego, explained this recommendation, saying, “young children under 2 years of age are at high risk just by age alone even if they don’t have any other underlying disease.”

Another difference concerns HPV vaccination. The AAP recommends two doses for children aged 9–12 years, while the CDC recommends one dose at ages 11–12. “The evidence of two doses versus one is still under review. Until then, the AAP continues to recommend two doses to ensure protection,” said Dr. Pannaraja.

Overall, the AAP’s 2026 recommendations closely mirror those released in August 2025.

AAP Leadership Statements and Endorsing Organizations

AAP President Andrew Racine, MD, PhD, FAAP, said the organization’s decision reflects its ongoing approach to vaccine guidance, “The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children and adolescents of this country.”

The AAP’s immunization schedule has been formally endorsed by 12 medical and healthcare organizations representing more than one million healthcare professionals. These include the American Academy of Family Physicians, American College of Nurse Midwives, American College of Obstetricians and Gynecologists, American Medical Association, American Pharmacists Association, Council of Medical Specialty Societies, Infectious Diseases Society of America, National Association of Pediatric Nurse Practitioners, National Medical Association, Pediatric Infectious Diseases Society, Pediatric Pharmacy Association, and the Society for Adolescent Health and Medicine.

Ongoing Developments and the Role of Health Care Providers

The AAP is challenging the federal government’s changes to the CDC schedule, citing concerns about the removal of universal guidelines and the process used to implement the updates. The organization noted that the CDC did not reference new data or hold a public meeting with the Advisory Committee on Immunization Practices (ACIP) before issuing the revisions.

On January 19, the 12 medical and health organizations endorsing the AAP’s schedule filed an amended complaint seeking to halt the implementation of the new federal child and adolescent immunization schedule.

Additionally, the AAP, along with more than 200 medical, public health, and patient advocacy groups, urged Congress to protect vaccine access, warning that conflicting guidance could confuse families and result in delayed or missed vaccinations.

Even while the CDC’s schedule remains under review, AAP infectious disease experts encourage pediatricians to continue following the AAP schedule and act as a reliable source of information for families. As COID Chair Sean T. O’Leary, M.D., M.P.H., FAAP, stated, “Following our schedule on time remains the best way to ensure children receive the strongest possible protection. We’ll be working with our partners across medicine and public health to ensure that parents have credible, science-backed vaccine recommendations they can trust.”

Dr. O’Leary further highlighted the pediatrician’s role in helping parents navigate conflicting information: “Our role as pediatricians is to cut through all that noise and understand what the science actually shows so that parents can make informed decisions with confidence alongside their pediatrician.”

Dr. Racine has also emphasized the importance of routine immunizations and the conversations between healthcare providers and the patient’s parent or caregiver, saying, “Routine childhood immunizations are an important early step in the path to lifelong health… your pediatrician welcomes conversations about all your child’s health care, including immunizations.”

Practical Steps for Clinicians

As differences between national immunization schedules continue to evolve, clinicians play a central role in interpreting guidance and communicating evidence-based recommendations to families. Reviewing the AAP’s 2026 Recommended Childhood and Adolescent Immunization Schedule, the CDC’s updated guidance, and relevant statements or clinical resources from professional organizations can help clinicians address questions from patients, parents, or guardians and support consistent, informed communication in clinical settings.

We’ve included resources below and will continue to provide our members with additional information as it becomes available.

News Release from the AAP
2026 AAP Immunization Schedule
AAP Immunization Resource Website
AAP’s Policy Statement for the 2026 Immunization Schedule
Simplified 2026 AAP Vaccine Guide for Parent/Caregivers

Filed Under: Physician Buying Group

CDC Vaccine Schedule Changes: Revised Childhood and Adolescent Immunization Schedules

On January 5, 2026, the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) recommended that the childhood and adolescent immunization schedule be revised.

As part of the review, HHS and CDC examined best-practice childhood and adolescent immunization schedules from other developed countries, along with the underlying evidence and data supporting the vaccines. The new recommendation decreases the number of vaccines recommended for all children. Additional vaccines should be considered for children and adolescents in certain high-risk groups or populations, and other vaccines are recommended based on shared clinical decision-making between the health care provider and the patient or parent/guardian.

What Does “Shared Clinical Decision-Making” Mean for Vaccinations?

When the CDC and FDA recommend a vaccination as a shared clinical decision-making vaccination, it means that it is not routinely recommended for all patients. For example, unlike routine, catch-up, and risk-based recommendations, shared clinical decision-making recommendations are individually tailored and made through an informed decision-making process between healthcare professionals and the patient or the patient’s parent/guardian. This approach emphasizes personalized care, requiring thoughtful discussion and follow-up to ensure timely administration of all vaccine doses.

Why Did the HHS and the CDC Decide to Revise the Schedule?

Building on this approach, federal officials note that one of the reasons for the revised schedule is to increase vaccine uptake and trust. They hope that recommending fewer vaccines for all children and adolescents, and removing vaccines some deem unnecessary for healthy children from the standard schedule, will improve acceptance.

Vaccines recommended for all children include:

  • Measles, mumps, rubella
  • Diphtheria, tetanus, pertussis
  • Polio
  • Haemophilus influenzae type B (Hib)
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Varicella

Vaccines recommended for high-risk populations include:

  • Respiratory syncytial virus (RSV) monoclonal antibodies
  • Hepatitis A
  • Hepatitis B
  • Meningococcal ACWY
  • Dengue

Vaccines recommended for shared clinical decision making include:

  • Hepatitis A
  • Hepatitis B
  • Rotavirus
  • Meningococcal B
  • Influenza
  • COVID-19

For the vaccines recommended for shared clinical decision-making, health care providers, parents/guardians, and patients should decide together whether they are appropriate on a patient-to-patient basis. Decisions should be based on the individual’s characteristics, values, and preferences; the provider’s medical judgment; and the characteristics of the vaccine being considered.

Will Insurance Coverage Now Change Based on this Decision?

Insurance coverage of ALL vaccines for ALL patients, regardless of recommendation category, will remain in effect. This provides assurance to both physicians and patients that if they determine a specific vaccine is recommended or desired, insurance will cover it with no out-of-pocket expense.

A fact sheet for this decision provided by the CDC explains insurance coverage in further detail: All immunizations recommended by the CDC as of December 31, 2025, will continue to be fully covered by Affordable Care Act insurance plans and federal insurance programs, including Medicaid, the Children’s Health Insurance Program, and the Vaccines for Children program. Families will not have to purchase them out of pocket. This means that insurance will continue to cover more vaccines for children in the U.S. than in peer nations, where insurance generally only pays for recommended vaccines.

What’s Next?

The CDC fact sheet also outlines the agency’s next steps: The CDC will continue to closely monitor vaccine uptake, infectious disease rates, and vaccine safety. For health care providers, the CDC will publish the updated Child and Adolescent Immunization Schedule by Age (through age 18), including immunization recommendations for all children, guidance for certain high-risk groups or populations, and vaccines recommended through shared clinical decision-making.

HHS will work with states and physician groups to educate parents and providers on the updated CDC childhood immunization schedule. The CDC will continue to closely monitor vaccine uptake, infectious disease rates, and vaccine safety.

At this time, we recommend that our members review the full HHS decision memo, the updated vaccine schedules, the CDC fact sheet, and any guidance from their professional organizations to prepare for questions from patients and parents or guardians. These resources are attached below.

We will continue to provide our members with additional information as it becomes available.

HHS Vaccine Schedule Decision Memo
Revised Immunization Schedules
CDC Childhood Vaccine Fact Sheet

Filed Under: Physician Buying Group Tagged With: CDC, Shared Decision Making, Vaccine Schedules

As the year wraps up and with increased flu-season demand and upcoming holiday closures, it’s more important than ever to plan ahead. We understand how critical it is for your clinic to receive the vaccines and supplies you need on time, especially during your busiest months. Ensuring that our members have what they’ve ordered when they need it is a priority we take seriously.

To help your clinic stay prepared and avoid shipment delays, we’ve outlined the holiday shipping timelines from Merck, Pfizer, and Sanofi for the remainder of December and the beginning of January. Reviewing these schedules now will help ensure your orders arrive without interruption and your team can continue providing seamless, high-quality care to your patients.

Merck 2025-26 Holiday Shipping ScheduleDownload
2025 SanofiHolidayShippingScheduleDownload
Pfizer 2025-26 Holiday Shipping ScheduleDownload

Filed Under: Physician Buying Group

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Address

240 N. East Promontory Suite 200
Farmington, UT 84025

Directions

NAVIGATION

  • Why A Buying Group
  • Why Choose PCA
  • Manufacturing Partners
  • Resources
  • VACCINESHOP
  • Contact Us
  • Member Login

Contact Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*

2026

Primary Care Alliance

All Rights Reserved

Privacy Policy

Terms

Sitemap

XML Sitemap

Site by PDM